Author:
Kapoor Raghav,Mehta Anurag,Sharma Anila,Nathany Shrinidhi,Diwan Himanshi,Bansal Divya
Abstract
AbstractMelanocytic lesions involving the central nervous system are extremely rare and pose a diagnostic challenge owing melanoma being the third most common malignancy metastasizing to the spine. Morphology and immunohistochemistry are identical in both primary and secondary cases, and hence may not help in rendering a final diagnosis. Molecular alterations involving melanomas of the spine and melanomas elsewhere are distinct and help establish the appropriate diagnosis. We report an interesting case where molecular profiling of the tumor tissue helped render the final diagnosis.
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Majeed K, Hussain I, Pisapia DJ, Song W, Baaj AA, Stieg PE. Intradural Intramedullary primary spinal melanoma: a Case Report and Review of the literature -. Sci J Neurol Neurosurg. 2019;5(1):12–8.
2. Cornejo KM, Hutchinson L, Cosar EF, et al. Is it a primary or metastatic melanocytic neoplasm of the central nervous system ? A molecular based approach. Pathol Int. 2013;April559–64. https://doi.org/10.1111/pin.12107.
3. Ominato J, Fukuchi T, Sato A, Yamaguchi N. The role of mutation rates of GNAQ or GNA11 in cases of Uveal Melanoma in Japan. Appl Immunohistochem Mol Morphol. 2018;26(9):658–63.
4. Klaasen A, Ku B, Grunsven IACHVE, Dijk MRCF, Van, Reifenberger G. Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol. 2010;317–23. https://doi.org/10.1007/s00401-009-0611-3.
5. Helga C, Le D, Metz KA et al. GNAQ Q209R Mutations Are Highly Specific for Circumscribed Choroidal Hemangioma. Cancers (Basel). 2019:1–11.